Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2009 Apr;47(4):969-74.
doi: 10.1128/JCM.00651-08. Epub 2009 Feb 11.

Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates

Affiliations
Multicenter Study

Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates

Azita Leavitt et al. J Clin Microbiol. 2009 Apr.

Abstract

Ertapenem resistance in Klebsiella pneumoniae is rare. We report on an ertapenem-nonsusceptible phenotype among 25 out of 663 (3.77%) extended-spectrum-beta-lactamase (ESBL)-producing K. pneumoniae isolates in a multicenter Israeli study. These isolates originated from six different hospitals and were multiclonal, belonging to 12 different genetic clones. Repeat testing using Etest and agar dilution confirmed ertapenem nonsusceptibility in only 15/663 (2.3%) of the isolates. The molecular mechanisms of ertapenem resistance in seven single-clone resistant isolates was due to the presence of ESBL genes (CTX-M-2 in four isolates, CTX-M-10 and OXA-4 in one isolate, SHV-12 in one isolate, and SHV-28 in one isolate) combined with the absence of OMPK36. Seven of 10 isolates initially reported as ertapenem nonsusceptible and subsequently classified as susceptible showed an inoculum effect with ertapenem but not with imipenem or meropenem. Population analysis detected the presence of an ertapenem-resistant subpopulation at a frequency of 10(-6). These rare resistant subpopulations carried multiple ESBL genes, including TEM-30, SHV-44, CTX-M-2, and CTX-M-10, and they lacked OMPK36. The clinical and diagnostic significance of the results should be further studied.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Population analysis of four ESBL-producing Klebsiella pneumoniae strains with and without an inoculum effect. The distribution of the resistant subpopulation among the population of two ertapenem-sensitive strains that possess an inoculum effect (strains 5 and 7) differed from the population distribution of a stable ertapenem-resistant strain (strain 490) and that of an ertapenem-sensitive strain (strain 8). Strains 5 and 7 showed the preexistence of a rare ertapenem-resistant subpopulation absent in strain 8 that may lead to discrepancies in ertapenem susceptibility test results for the inoculum effect strains.
FIG. 2.
FIG. 2.
(A) OMP profiles of ertapenem-sensitive K. pneumoniae isolates and ertapenem-resistant isolates (ertapenem-S and ertapenem-R, respectively). OMPK36 was present in ertapenem-sensitive isolates (K. pneumoniae ATCC strain 13883 [ATCC] and isolates 5 and 7, the two sensitive isolates with a positive inoculum effect). M, molecular size marker. (B) The OMP profile of isolate 7 (possessing an inoculum effect) with ertapenem (7+ERT) and without ertapenem (7) in growth medium demonstrated a lack of OMPK36 in the presence of the antibiotic similarly to the OMP pattern of resistant strains, supporting the preexistence of a resistant subpopulation that remains viable in the presence of ertapenem.

References

    1. Afzal-Shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45583-588. - PMC - PubMed
    1. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-ß-lactamase-producing gram-negative bacteria using thiol compounds. J. Clin. Microbiol. 3840-43. - PMC - PubMed
    1. Bauvois, C., A. S. Ibuka, A. Celso, J. Alba, Y. Ishii, J. M. Frere, and M. Galleni. 2005. Kinetic properties of four plasmid-mediated AmpC β-lactamases. Antimicrob. Agents Chemother. 494240-4246. - PMC - PubMed
    1. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahaland, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41563-569. - PMC - PubMed
    1. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14933-951. - PMC - PubMed

Publication types

MeSH terms